Last updated on December 2018

An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)


Brief description of study

The purpose of this study is to investigate the superiority of KPS-0373 to placebo, and evaluate the safety of KPS-0373 in SCD patients.

Clinical Study Identifier: NCT02889302

Contact Investigators or Research Sites near you

Start Over

Kissei Pharmaceutical Co., Ltd

Tokyo and Other Japanese City, Japan

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.